Observational studyMolecular oncology2021

Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration-resistant prostate cancer undergoing first-line abiraterone acetate and prednisone treatment.

Emmy Boerrigter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.